Targacept stops Alzheimer's drug trial after it fails mid-stage
(Reuters) - Targacept Inc said its experimental Alzheimer's drug did not show superiority over standard medication in a mid-stage study and that it would no longer invest in the development of the treatment. The company's shares were down ...
Even a Little Walking Can Lengthen Your Life
Less than the recommended 150 minutes a week still seemed to help, study found